Jun

23

2026

Hamlet BioPharma invites you to our monthly investors’ meeting to be held on the 30th of June 2026, at 12:00. Please click on the link below to partic...

Jun

22

2026

Hamlet BioPharma AB (publ) today announced the signing of a clinical trial agreement with the University of Iowa, one of the leading U.S. centers for ...

Jun

17

2026

Hamlet BioPharma AB (publ) today conducted a pre-initiation visit at the Department of Urology at Charles University, Prague, led by Professor Marek B...

Jun

10

2026

The Journal of Infectious Diseases publishes the paper “Targeting the disease response with NlpD and LytM for effective non-antibiotic treatment of ur...

Jun

08

2026

Hamlet BioPharma AB (publ) meddelar idag att bolaget inlett ett samarbete med University of IOWA, ett amerikanskt center inom uro-onkologi med fokus p...

May

22

2026

  ...

May

21

2026

Hamlet BioPharma invites you to the investors’ meeting to be held on the 22nd of May 2026, at 12:00. Please click on the link below to participate in ...

May

18

2026

Hamlet Biopharma, a company innovating the treatment of cancer and infections, today announced the successful granting of new patents in Japan and Ind...

Apr

23

2026

Hamlet BioPharma invites you to the monthly digital investors’ meeting to be held on the 29th of April 2026, at 12:00. Please click on the link below ...

Mar

30

2026

Hamlet BioPharma AB, an innovative pharmaceutical company developing new therapies for cancer and infections, announces that the company presented its...